M&A & BD&L Outlook and Perspectives on Commercial Due Diligence

Please join our M&A, BD&L and Commercial Due Diligence (CDD) leaders to discuss our current perspectives on the state of deal-making in the pharmaceutical and biotech sectors, and to discuss our point of view on the heightened importance of Commercial Due Diligence in the current market and how to optimize CDD efforts using best practices and risk mitigation techniques.

Webinar Presenters

EVERSANA M&A Partners

James Stephanou Partner, Strategy, M&A and Business Development

Faruk Abdullah President, Professional Services and Chief Business Officer

Industry Co-Presenters

Jakub Pijewski, PhD Vice President, US Commercial Strategy, Partnerships and BD&LGSK

Yao Zhang, PhD Senior Director, Interventional Oncology, Johnson & Johnson Innovation